Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 04, 2022 02:08 ET | Source: BTG Specialty Pharmaceuticals

SERB acquires the rights to Xermelo® outside US and Japan for Carcinoid Syndrome Diarrhoea

Paris, April 04, 2022 (GLOBE NEWSWIRE) -- SERB is pleased to announce it has acquired the rights from Ipsen to commercialize Xermelo® (telotristat ethyl) in Europe and other countries outside the US...